Event Abstract Back to Event CLINICAL NUTRITION PROGRAM IMPROVES CHRONIC FATIGUE AND INTESTINAL PAIN IN 50 YEAR OLD MAN WITH HASHIMOTO’S David J. Clark1* 1 Carrick Institute, United States Background: A 50 year old man presented with a history of chronic fatigue, gastrointestinal pain, cramping and gas. Within one hour after eating he experienced pain and gas, and then 3 to 4 hours later, he suffered severe lower intestinal cramping. He also suffered constipation (only one to two bowel movements per week). Frequently, a few hours after waking , he would be so fatigue that he needed to nap. This also occurred after doing any kind of exercising such as cycling. Eight years prior to presentation he was diagnosed with hypothyroidism and prescribed levothyroxine. Three years later he demonstrated elevated thyroid autoantibodies (Hashimoto’s) and was switched to bioidentical thyroid replacement. He followed various interventions including acupuncture, low FODMAPS diet and Small Intestine Bacterial Overgrowth protocol— but with no positive effects on his symptoms. He followed a gluten-free diet at time of presentation. He was taking Armour daily as well as vitamin D. Methods: Blood chemistry revealed high homocysteine (13.9), potassium (5.4), TSH (13.26), TPO antibodies (144) and thyroglobulin antibodies (2), low HDL (39), T4 (4.2), Reverse T3 (6), free T4 (0.7), normal T3 and Free T3, clinically significantly high BUN (25), clinically significantly low B12 (375), vitamin D (35). Urea Breath Test for H. pylori was negative. Urinary Organic Acids testing revealed high Arabinose (36), 4-Hydroxybenzoic (0.90), oxalic (135), 3-Hydroxyglutaric (6.8), Suberic (4.0), and 2-Hydroxyhippuric (1.2) acids. Dried urine testing for hormones revealed low levels of epitestosterone, clinically significantly low levels of beta-pregnanediol, alpha-pregnanediol, DHEA sulfate, androsterone, testosterone, 5-alpha DHT, He was placed on an anti-inflammatory diet and a supplement protocol utilizing turmeric, resveratrol, sublingual vitamin D, high EPA fish oil, broad-spectrum digestive enzyme formula, pregnenolone, a multi-nutrient formula for lowering homocysteine and a multi-multi-nutrient formula for support of normal tissue glucose levels. Results: At 60 day follow up, the patient reported a 60% increase in his energy. He no longer needed to nap in the mornings, nor after exercise. He reported a 50% improvement in the frequency of gastrointestinal pain and cramping. Frequency of bowel movements had increased to four to five times per week. In addition, blood chemistry showed improved B12 (580), vitamin D (68.4), homocysteine (11.1). Conclusion: The author suggests further investigation into clinical nutrition, diet and supplementation in the treatment of chronic fatigue and gastrointestinal complaints in patients with Hashimoto’s. Keywords: Hashimoto's autoimmune thyroiditis, HPA axis (hypothalamus-pituitary-adrenal), supplementation, Anti-inflammatory diet, Clinical Nutrition Conference: International Symposium on Clinical Neuroscience, Orlando, United States, 24 May - 26 May, 2019. Presentation Type: Poster Presentation Topic: Clinical Neuroscience Citation: Clark DJ (2019). CLINICAL NUTRITION PROGRAM IMPROVES CHRONIC FATIGUE AND INTESTINAL PAIN IN 50 YEAR OLD MAN WITH HASHIMOTO’S. Front. Neurol. Conference Abstract: International Symposium on Clinical Neuroscience. doi: 10.3389/conf.fneur.2019.62.00025 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 02 Apr 2019; Published Online: 27 Sep 2019. * Correspondence: Mx. David J Clark, Carrick Institute, Cape Canaveral, Florida, 32920, United States, mail@doctordavidclark.com Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers David J Clark Google David J Clark Google Scholar David J Clark PubMed David J Clark Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.